Literature DB >> 16328757

[Early diagnosis of Lyme arthritis].

A Krause1, P Herzer.   

Abstract

Lyme-Arthritis is one of the most frequent manifestations of Lyme disease. Transient arthritides may already develop in the early disease stage. However, typical Lyme arthritis manifests weeks to months after the infection as intermittent mon- or oligoarthritis predominantly affecting the knees. Massive knee effusions may lead to popliteal cysts that often rupture. Chronic arthritides are rare. The diagnosis of Lyme arthritis mainly is based on clinical grounds and confirmed by laboratory tests. Direct detection of the causing agent by culture is difficult and not suitable for clinical use. With polymerase chain reaction based assays in up to 80% of untreated patients with Lyme arthritis B. burgdorferi DNA can be detected in joint fluid or synovial membrane specimens. While this method is not widely available yet it will become a routine diagnostic tool in Lyme arthritis in the near future. Borrelia serology is still the most important laboratory test. A negative serology almost certainly rules out Lyme arthritis. A positive serology alone, however, does not proof Lyme disease and must be critically interpreted in context with clinical symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16328757     DOI: 10.1007/s00393-005-0793-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  9 in total

Review 1.  [Lyme borreliosis].

Authors:  H I Huppertz; A Krause
Journal:  Internist (Berl)       Date:  2003-02       Impact factor: 0.743

2.  European Concerted Action on Lyme Borreliosis (EUCALB).

Authors:  S O Connell
Journal:  Euro Surveill       Date:  1996-03

Review 3.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

4.  Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy.

Authors:  S Priem; G R Burmester; T Kamradt; K Wolbart; M G Rittig; A Krause
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

5.  Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis.

Authors:  J D Lünemann; S Zarmas; S Priem; J Franz; R Zschenderlein; E Aberer; R Klein; L Schouls; G R Burmester; A Krause
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.

Authors:  J J Nocton; F Dressler; B J Rutledge; P N Rys; D H Persing; A C Steere
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

Review 7.  Diagnosis of lyme borreliosis in europe.

Authors:  Bettina Wilske
Journal:  Vector Borne Zoonotic Dis       Date:  2003       Impact factor: 2.133

8.  The clinical evolution of Lyme arthritis.

Authors:  A C Steere; R T Schoen; E Taylor
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

9.  Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Authors:  Rendi Murphree Bacon; Brad J Biggerstaff; Martin E Schriefer; Robert D Gilmore; Mario T Philipp; Allen C Steere; Gary P Wormser; Adriana R Marques; Barbara J B Johnson
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

  9 in total
  6 in total

1.  [Lyme borreliosis].

Authors:  P Herzer; V Fingerle; H-W Pfister; A Krause
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

2.  [Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Authors:  M Gaubitz; F Dressler; H I Huppertz; A Krause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

Review 3.  [PCR-based detection of pathogens in clinical rheumatology].

Authors:  B Ehrenstein; U Reischl
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

4.  [Lyme borreliosis].

Authors:  A Krause; V Fingerle
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

Review 5.  [Early rheumatoid arthritis--rapid help is double help].

Authors:  M Aringer; N Leuchten; K P Machold
Journal:  Z Rheumatol       Date:  2007-12       Impact factor: 1.372

6.  [Differential diagnosis of inflammatory arthritis of the hip joint].

Authors:  A Jablonka; R E Schmidt; D Meyer-Olson
Journal:  Unfallchirurg       Date:  2012-11       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.